Advanced Search
Article Contents
ABOUT THIS ARTICLE
The Innovation Medicine > 2026 Vol. 4 > No. 2 > 100208
Next Article Previous Article
COMMENTARY   Open Access     Cite

The dark side of immunity: From a byproduct of V(D)J recombination to a promoter of leukemic relapse

  • 1.

    Shanghai institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China

  • 2.

    Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

More Information
  • Corresponding author: lwang@sinh.ac.cn
  • Received Date:  October 12, 2025
    Accepted Date:  March 18, 2026
    Published Online:  March 19, 2026
The Innovation Medicine  4(2),  https://doi.org/10.59717/j.xinn-med.2026.100208  |  Cite this article
    • FullText(HTML)
  • 加载中
    • REFERENCES
  • [1] Gao Z., Scott J.N.F., Edwards M.P., et al. (2025). Excised DNA circles from V(D)J recombination promote relapsed leukaemia. Nature 645:774−783. DOI:10.1038/s41586-025-09372-6

    View in Article CrossRef Google Scholar

    [2] Mullighan C.G., Phillips L.A., Su X., et al. (2008). Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science 322:1377−1380. DOI:10.1126/science.1164266

    View in Article CrossRef Google Scholar

    [3] Turner K.M., Deshpande V., Beyter D., et al. (2017). Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity. Nature 543:122−125. DOI:10.1038/nature21356

    View in Article CrossRef Google Scholar

    [4] Papaemmanuil E., Rapado I., Li Y., et al. (2014). RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia. Nat. Genet. 46:116−125. DOI:10.1038/ng.2874

    View in Article CrossRef Google Scholar

    [5] Smith A.L., Scott J.N.F. and Boyes J. (2019). The ESC: The dangerous by-product of V(D)J recombination. Front. Immunol. 10:1572. DOI:10.3389/fimmu.2019.01572

    View in Article CrossRef Google Scholar

    • Cited by

  • Cite this article:

    Li Z., Chang B., Wang Y., et al. (2026). The dark side of immunity: From a byproduct of V(D)J recombination to a promoter of leukemic relapse. The Innovation Medicine 4:100208. https://doi.org/10.59717/j.xinn-med.2026.100208
    Li Z., Chang B., Wang Y., et al. (2026). The dark side of immunity: From a byproduct of V(D)J recombination to a promoter of leukemic relapse. The Innovation Medicine 4:100208. https://doi.org/10.59717/j.xinn-med.2026.100208

Welcome!

To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.

PDF
Figures(1)    

Share

  • Share the QR code with wechat scanning code to friends and circle of friends.

Article Metrics

Article views(1102) PDF downloads(251)

Relative Articles

Cited by

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return

    {{newsColumn.name}}

    {{newsColumn.name}}

    Stay connected

    {{newsColumn.name}}

    Website copyright © Innovation Press. Published articles are licensed under CC BY with copyright retained by the authors.